Jim Cramer's Top 12 Must-Watch Stocks feature Verve Therapeutics Inc. (NASDAQ:VERV) for its innovative gene-editing technology targeting cardiovascular diseases. With strong leadership and promising clinical trials, VERV holds potential for growth in the health sector.